financetom
Business
financetom
/
Business
/
Kopin Partners With Wilcox Industries For Modular Dismounted Soldier System
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kopin Partners With Wilcox Industries For Modular Dismounted Soldier System
Jul 15, 2024 1:57 PM

04:41 PM EDT, 07/15/2024 (MT Newswires) -- Kopin ( KOPN ) said late Monday it is collaborating with Wilcox Industries on the Fusion Claw head borne information system.

The Fusion Claw is set to revolutionize the battlefield with its advanced modular technology platform, integrating night vision, communications equipment, Day/Night Heads-Up Display, among others, into a single package, the company said.

Kopin ( KOPN ) said its role involves the development and production of look-through mixed reality accessories, which could enhance warfighter situational awareness with Day and Night HUDs.

Shares of Kopin ( KOPN ) rose more than 3% in after-hours activity.

Price: 1.1201, Change: +0.04, Percent Change: +3.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Verisign Insider Sold Shares Worth $2,545,871, According to a Recent SEC Filing
Verisign Insider Sold Shares Worth $2,545,871, According to a Recent SEC Filing
Jun 20, 2025
04:47 PM EDT, 06/20/2025 (MT Newswires) -- D James Bidzos, Director, Executive Chairman, President, & CEO, on June 17, 2025, sold 9,000 shares in Verisign ( VRSN ) for $2,545,871. Following the Form 4 filing with the SEC, Bidzos has control over a total of 531,772 common shares of the company, with 531,772 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1014473/000120481625000014/xslF345X05/wk-form4_1750452253.xml ...
Incyte Says FDA Extends Review Period for Ruxolitinib Cream
Incyte Says FDA Extends Review Period for Ruxolitinib Cream
Jun 20, 2025
04:49 PM EDT, 06/20/2025 (MT Newswires) -- Incyte ( INCY ) said Friday the US Food and Drug Administration has extended the review period for the supplemental new drug application for ruxolitinib cream to treat children with mild to moderate atopic dermatitis. The prescription drug user fee act action date has been extended to Sept. 19, Incyte ( INCY )...
Ensign Group Insider Sold Shares Worth $731,445, According to a Recent SEC Filing
Ensign Group Insider Sold Shares Worth $731,445, According to a Recent SEC Filing
Jun 20, 2025
04:48 PM EDT, 06/20/2025 (MT Newswires) -- Beverly B. Wittekind, Vice President and Chief Legal Officer, on June 18, 2025, sold 4,719 shares in Ensign Group ( ENSG ) for $731,445. Following the Form 4 filing with the SEC, Wittekind has control over a total of 38,679 common shares of the company, with 38,679 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1125376/000112537625000117/xslF345X05/wk-form4_1750452238.xml...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved